Accounting for susceptibility in risk assessment: The need for full disclosure

By Fowle III J.R.  

Environmental Toxicology and Pharmacology, Vol. 4, Iss. 3, 1997-12 ,pp. : 247-250

Elsevier

Access to resources Recommend Favorite

Pharmacotherapy of postpartum depression: current practice and future directions

By Tcheremissine Oleg V   Lieving Lori M  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 12, 2005-10 ,pp. : 1999-2005

Informa Healthcare

Access to resources Recommend Favorite

Risk Assessment Practice for Essential Metals

By Meek M. E.   Levy Leonard   Beck Barbara   Danzeisen Ruth   Donohue Joyce   Arnold Ian   Krewski Daniel  

Journal of Toxicology and Environmental Health, Vol. 73, Iss. 2-3, 2010-01 ,pp. : 253-260

Taylor & Francis Ltd

Access to resources Recommend Favorite

Pharmacotherapy of Hyperlipidemia in Pediatric Heart Transplant Recipients: Current Practice and Future Directions

By Chin Clifford   Bernstein Daniel  

Pediatric Drugs, Vol. 7, Iss. 6, 2005-01 ,pp. : 391-396

Adis International

Access to resources Recommend Favorite

Targeted Approaches to Triple-Negative Breast Cancer: Current Practice and Future Directions

By  

Current Medicinal Chemistry, Vol. 20, Iss. 5, 2013-02 ,pp. : 605-612

Bentham Science Publishers

Access to resources Recommend Favorite